Ningbo Menovo Pharmaceutical Co Ltd
603538
Company Profile
Business description
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
Contact
No.999,Yangfan Road
Room 1406, No.1
High-tech Zone
Ningbo315040
CHNT: +86 57487357091
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
2,370
Stocks News & Analysis
stocks
AI stocks stumble amid growing safety fears
Warnings from Anthropic, OpenAI, and SpaceX are raising questions over the future of the AI buildout.
stocks
Chart of the Week: BHP’s valuation hits historic levels
BHP and peers are trading as if the copper boom is here to stay.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,922.70 | 11.80 | 0.13% |
| CAC 40 | 8,065.02 | 121.91 | -1.49% |
| DAX 40 | 25,304.06 | 412.65 | -1.60% |
| Dow JONES (US) | 51,682.64 | 95.40 | -0.18% |
| FTSE 100 | 10,659.13 | 157.01 | -1.45% |
| HKSE | 24,750.78 | 146.49 | 0.60% |
| NASDAQ | 26,522.54 | 104.25 | 0.39% |
| Nikkei 225 | 65,018.95 | 882.70 | 1.38% |
| NZX 50 Index | 13,739.14 | 17.45 | -0.13% |
| S&P 500 | 7,650.50 | 12.74 | 0.17% |
| S&P/ASX 200 | 8,731.20 | 1.20 | -0.01% |
| SSE Composite Index | 3,911.87 | 36.27 | 0.94% |